Our results showed that BCL6 protein was decreased in the patients with NAFLD than in the normal subjects (Fig. 1E, F), whereas no significant difference was observed in mRNA expression of BCL6. Here, BCL6 is linked to metabolic dysfunction-associated steatotic liver disease.